We are proud to highlight our grantee, Every Cure, for their innovative use of artificial intelligence in drug repurposing. By analyzing vast datasets, they identify existing medications that can be effectively used to treat other diseases, accelerating the discovery of new therapies and reducing development costs. This approach not only brings hope to patients with limited treatment options but also exemplifies the transformative potential of AI in healthcare.
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
We are thrilled to share that?The New York Times has just featured Every Cure and our work?using repurposed?drugs?to save lives. The article highlights how our AI-driven approach is identifying lifesaving treatments that were hiding in plain sight. It tells the powerful story of?patient?Joseph Coates,?who at 37 years old?was given just weeks to live due to a rare disease—until an AI-predicted treatment,?helped save his life. This recognition is a testament to our mission: ensuring that every FDA-approved drug is fully utilized to treat every disease it possibly can. We are incredibly grateful for the opportunity to shed light on this critical work and the potential AI holds for revolutionizing medicine. Click the link below to read the full article! https://lnkd.in/e-H8nyCZ #EveryCure #DrugRepurposing #AIforGood #HealthcareInnovation #raredisease #NYTimes